The device is worn by patients at risk of ventricular tachycardia or ventricular fibrillation during their hospital stays to monitor for irregular heart rhythms.
When the Hospital Wearable Defibrillator detects a life-threatening heart rhythm, it alerts the patient prior to administering a treatment shock. The device is programmed to deliver fibrillation within 60 seconds of the detected irregularity, according to a company news release.
More articles on supply chain:
Viewpoint: Trump is ‘crying wolf’ on drug price measures
6 must-reads for supply chain leaders this week
Trump nominates Dr. Scott Gottlieb for FDA commissioner: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
